mProve aims to ‘go beyond’ patient engagement with study services hub

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Pinkypills)
(Image: iStock/Pinkypills)

Related tags: Clinical data acquisition, Clinical trial protocol

mProve Health has partnered with Greenphire to provide payment solutions on its patient engagement app – bringing it one step closer to creating a mobile hub for all study services, says CEO.

mProve Health provides mobile technology for patient engagement and electronic clinical outcome assessments (eCOA). Greenphire is a clinical payment automation company.

Through the companies’ partnership, clinical trial participants receiving payments or reimbursements via Greenphire’s ClinCard will gain real-time access to their balance and payment history through mProve’s app, mPal.

Giving patients transparency into payment balance and transactions, along with immediate access to funds via their ClinCard, eliminates any financial hurdles that might deter a participant from fulfilling their study commitments or continuing in the trial,​” Jeff Lee, CEO at mProve Health told Outsourcing-Pharma.com. “It’s only fitting to combine these solutions in a single, mobile app.​”

mProve launched its combined patient engagement and electronic patient reported outcomes (ePRO) app in 2013. As Outsourcing-Pharma.com previously reported​, the company has been growing in response to demand for patient-operated mobile technology in clinical trials.

The vision for our mPal solution is to go beyond standard patient engagement and ePRO, to create a mobile hub that includes all study services (i.e. transportation, lab courier, etc.) in a single solution​,” explained Lee.

Adding patient payment information via the integration with Greenphire’s ClinCard brings us one step closer to offering patients all the services they could need for any trial,​” he said.

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars